Has Richard Stock, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,086 in general payments to Richard Stock, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Stock, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Stock, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Stock, MD

Radiation Oncology · New York, NYNPI 1497726970

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,630 of the $11,086 with a category attached, or 77.8%. 5 manufacturers reported payments, led by Bayer at 51.9% of the total. Among radiation oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,086in general payments, 2019–2025

Across 14 payments — averaging $791.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$6K
Pfizer$3K
Accuray Incorporated$2K
Boston Scientific$329
Astellas Pharma US Inc$93

What the payments were for

Consulting fees$8,63078%
Speaking & faculty fees$1,50014%
Food & beverage$9569%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	1	$5,750
Pfizer	4	$3,228
Accuray Incorporated	4	$1,686
Boston Scientific	4	$329
Astellas Pharma US Inc	1	$93

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,086 in reported general payments places this provider in the 90th percentile of 397 radiation oncology providers in New York.

See all radiation oncology providers in New York →

Medicare billing

Part B allowed, 2024

$331,949

Medicare patients

322

Services billed

3,136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	38	$291

Paid to pharmacies, not to this prescriber.

Other radiation oncology in New York

Michael ZelefskyNew York$946K
Nancy LeeNew York$233K
Robert SamsteinNew York$125K
Jalal AhmedNew York$100K
Charles SimoneNew York$84K
Silvia FormentiNew York$57K
Brandon ImberNew York$44K
Himanshu NagarNew York$43K
Chiaojung TsaiNew York$38K
Christopher BarkerNew York$32K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →